Category Archives: TRIPS

WIPO: Proposal to amend PCT Regulations undermines TRIPS flexibilities

Geneva, 15 June (TWN) – A proposal to amend a treaty regulation at the World Intellectual Property Organization (WIPO) will compromise TRIPS flexibilities, especially in relation to the scope of patentability for national patent offices. The International Bureau (i.e. WIPO … Continue reading

Posted in Patent, TRIPS, TRIPS flexibilities, TRIPS plus, TRIPS&IP rights, Uncategorized, WIPO | Leave a comment

WHO: Proposed work program on “fair price” undermines affordability of medicines

Source: The Third World Network | May 21, 2018 by KM Gopakumar Geneva:  The proposed work program on fair price raises concerns on affordability of medicines. The document was prepared by the Secretariat of the World Health Organization (WHO)for the … Continue reading

Posted in Access to Medecines, Drug prices, Pricing, TRIPS, TRIPS flexibilities, Uncategorized | Leave a comment

Prices of Patented Medicines in India

Source: Economic & Political Weekly | Vol. 53, Issue No. 22, 02 Jun, 2018 by Sharmila Mary Joseph  & James J Nedumpara To Regulate or Not to Regulate? Medicines with valid patents generally enjoy exemption from price regulation in most countries. In India, … Continue reading

Posted in Access to Medecines, Doha Declaration, Patent, Patents, TRIPS, TRIPS flexibilities, TRIPS plus, TRIPS&IP rights, Uncategorized | Leave a comment

For the first time the court has allowed the Russian pharmaceutical companies to produce a similar drug from USA

Source: HandofMoscow | June 3, 2018 by Andry Kut The arbitration court of Moscow satisfied the request of the Russian pharmaceutical company “Ukrenergo” on the issuance of a license to use a patent of the American Corporation Celgene in connection with a … Continue reading

Posted in Compulsory Licensing, Uncategorized | Leave a comment

New laws needed now to save lives: FTPL statement on new IP policy

  Source: Fix the Patent Laws Intellectual property policy welcomed after nine years of development JOHANNESBURG, 31 MAY 2018 – Yesterday, after nine years of development, the Department of Trade and Industry (the dti) finally published the Intellectual Property Policy of the … Continue reading

Posted in Compulsory Licensing, Doha Declaration, Fix the patent law, Patent Opposition, Patent Term Extension, TRIPS, Uncategorized | Leave a comment

Norwegian parliament turns down proposal to issue Spinraza compulsory license

On Thursday last week a majority vote in the Norwegian parliament Stortinget turned down a proposal to request that the Government issue a compulsory license for the drug Spinraza (nusinersen), which is used to treat the serious congenital condition Spinal … Continue reading

Posted in Access to Medicins, Compulsory Licensing | Leave a comment

Ingredients for WHO roadmap on access to medicines at civil society side event

Source: Intellectual Property Watch | May 25, 2018 On the side of this week’s World Health Assembly and hours before the Assembly agreed on preparing a roadmap on access to medicines, two civil society groups held an event on the … Continue reading

Posted in Access to Medecines, Cancer, IPR, TRIPS, WHO | Leave a comment